Pre-order Enquiry
Request Free Sample
Global and United States Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19208159 | Publishing Date : 23-Sep-2021 | No. of pages : 105
Detailed TOC of Global and United States Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Contract Manufacturing
1.2.3 Contract Research
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO and CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biologics Manuefacturing
1.3.3 Biosimilars Manuefacturing
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2016-2027)
2.2 Biopharmaceutical CMO and CRO Growth Trends by Regions
2.2.1 Biopharmaceutical CMO and CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical CMO and CRO Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical CMO and CRO Industry Dynamic
2.3.1 Biopharmaceutical CMO and CRO Market Trends
2.3.2 Biopharmaceutical CMO and CRO Market Drivers
2.3.3 Biopharmaceutical CMO and CRO Market Challenges
2.3.4 Biopharmaceutical CMO and CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO and CRO Revenue
3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2020
3.5 Biopharmaceutical CMO and CRO Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO and CRO Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO and CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO and CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2022-2027)
5 Biopharmaceutical CMO and CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceutical CMO and CRO Market Size (2016-2027)
6.2 North America Biopharmaceutical CMO and CRO Market Size by Type
6.2.1 North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical CMO and CRO Market Size by Application
6.3.1 North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical CMO and CRO Market Size by Country
6.4.1 North America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO and CRO Market Size (2016-2027)
7.2 Europe Biopharmaceutical CMO and CRO Market Size by Type
7.2.1 Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical CMO and CRO Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical CMO and CRO Market Size by Application
7.3.1 Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical CMO and CRO Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country
7.4.1 Europe Biopharmaceutical CMO and CRO Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical CMO and CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2016-2027)
9.2 Latin America Biopharmaceutical CMO and CRO Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AGC Biologics
11.1.1 AGC Biologics Company Details
11.1.2 AGC Biologics Business Overview
11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction
11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.1.5 AGC Biologics Recent Development
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.2.5 Boehringer Ingelheim International GmbH Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Inno Bio Ventures Sdn Bhd
11.4.1 Inno Bio Ventures Sdn Bhd Company Details
11.4.2 Inno Bio Ventures Sdn Bhd Business Overview
11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction
11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.4.5 Inno Bio Ventures Sdn Bhd Recent Development
11.5 JRS PHARMA
11.5.1 JRS PHARMA Company Details
11.5.2 JRS PHARMA Business Overview
11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction
11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.5.5 JRS PHARMA Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction
11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.6.5 Lonza Recent Development
11.7 PRA Health Sciences, Inc.
11.7.1 PRA Health Sciences, Inc. Company Details
11.7.2 PRA Health Sciences, Inc. Business Overview
11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction
11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.7.5 PRA Health Sciences, Inc. Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Details
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.8.5 ProBioGen AG Recent Development
11.9 Rentschler Biopharma SE
11.9.1 Rentschler Biopharma SE Company Details
11.9.2 Rentschler Biopharma SE Business Overview
11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction
11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.9.5 Rentschler Biopharma SE Recent Development
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021)
11.10.5 Samsung BioLogics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Contract Manufacturing
Table 3. Key Players of Contract Research
Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biopharmaceutical CMO and CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biopharmaceutical CMO and CRO Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biopharmaceutical CMO and CRO Market Share by Regions (2016-2021)
Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biopharmaceutical CMO and CRO Market Share by Regions (2022-2027)
Table 10. Biopharmaceutical CMO and CRO Market Trends
Table 11. Biopharmaceutical CMO and CRO Market Drivers
Table 12. Biopharmaceutical CMO and CRO Market Challenges
Table 13. Biopharmaceutical CMO and CRO Market Restraints
Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2016-2021)
Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO and CRO as of 2020)
Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biopharmaceutical CMO and CRO Product Solution and Service
Table 21. Date of Enter into Biopharmaceutical CMO and CRO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2016-2021)
Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biopharmaceutical CMO and CRO Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2016-2021)
Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million)
Table 61. AGC Biologics Company Details
Table 62. AGC Biologics Business Overview
Table 63. AGC Biologics Biopharmaceutical CMO and CRO Product
Table 64. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 65. AGC Biologics Recent Development
Table 66. Boehringer Ingelheim International GmbH Company Details
Table 67. Boehringer Ingelheim International GmbH Business Overview
Table 68. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product
Table 69. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 70. Boehringer Ingelheim International GmbH Recent Development
Table 71. FUJIFILM Diosynth Biotechnologies Company Details
Table 72. FUJIFILM Diosynth Biotechnologies Business Overview
Table 73. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product
Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 75. FUJIFILM Diosynth Biotechnologies Recent Development
Table 76. Inno Bio Ventures Sdn Bhd Company Details
Table 77. Inno Bio Ventures Sdn Bhd Business Overview
Table 78. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product
Table 79. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 80. Inno Bio Ventures Sdn Bhd Recent Development
Table 81. JRS PHARMA Company Details
Table 82. JRS PHARMA Business Overview
Table 83. JRS PHARMA Biopharmaceutical CMO and CRO Product
Table 84. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 85. JRS PHARMA Recent Development
Table 86. Lonza Company Details
Table 87. Lonza Business Overview
Table 88. Lonza Biopharmaceutical CMO and CRO Product
Table 89. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. PRA Health Sciences, Inc. Company Details
Table 92. PRA Health Sciences, Inc. Business Overview
Table 93. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product
Table 94. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 95. PRA Health Sciences, Inc. Recent Development
Table 96. ProBioGen AG Company Details
Table 97. ProBioGen AG Business Overview
Table 98. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 99. ProBioGen AG Recent Development
Table 100. Rentschler Biopharma SE Company Details
Table 101. Rentschler Biopharma SE Business Overview
Table 102. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product
Table 103. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 104. Rentschler Biopharma SE Recent Development
Table 105. Samsung BioLogics Company Details
Table 106. Samsung BioLogics Business Overview
Table 107. Samsung BioLogics Biopharmaceutical CMO and CRO Product
Table 108. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million)
Table 109. Samsung BioLogics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO and CRO Market Share by Type: 2020 VS 2027
Figure 2. Contract Manufacturing Features
Figure 3. Contract Research Features
Figure 4. Global Biopharmaceutical CMO and CRO Market Share by Application: 2020 VS 2027
Figure 5. Biologics Manuefacturing Case Studies
Figure 6. Biosimilars Manuefacturing Case Studies
Figure 7. Other Case Studies
Figure 8. Biopharmaceutical CMO and CRO Report Years Considered
Figure 9. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Biopharmaceutical CMO and CRO Market Share by Regions: 2020 VS 2027
Figure 12. Global Biopharmaceutical CMO and CRO Market Share by Regions (2022-2027)
Figure 13. Global Biopharmaceutical CMO and CRO Market Share by Players in 2020
Figure 14. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO and CRO as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2020
Figure 16. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2016-2021)
Figure 17. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2022-2027)
Figure 18. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Biopharmaceutical CMO and CRO Market Share by Type (2016-2027)
Figure 20. North America Biopharmaceutical CMO and CRO Market Share by Application (2016-2027)
Figure 21. North America Biopharmaceutical CMO and CRO Market Share by Country (2016-2027)
Figure 22. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biopharmaceutical CMO and CRO Market Share by Type (2016-2027)
Figure 26. Europe Biopharmaceutical CMO and CRO Market Share by Application (2016-2027)
Figure 27. Europe Biopharmaceutical CMO and CRO Market Share by Country (2016-2027)
Figure 28. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2016-2027)
Figure 38. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biopharmaceutical CMO and CRO Market Share by Type (2016-2027)
Figure 46. Latin America Biopharmaceutical CMO and CRO Market Share by Application (2016-2027)
Figure 47. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2016-2027)
Figure 48. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2016-2027)
Figure 54. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 58. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 60. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 61. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 62. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 63. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 64. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 65. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 66. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global and United States Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2021-2027
AGC BiologicsBoehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures Sdn Bhd
JRS PHARMA
Lonza
PRA Health Sciences, Inc.
ProBioGen AG
Rentschler Biopharma SE
Samsung BioLogics
Request Sample
Request Discount
